Expression of cd44 adhesion molecules in nonpapillary renal cell carcinoma and normal kidneys

Urology

Volumn 54, Issue 3, 1999, Pages 562-566

  Hara, Isao ^a   Miyake, Hideaki ^a   Yamanaka, Kazuki ^a   Hara, Shoji ^a   Arakawa, Soichi ^a   Kamidono, Sadao ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HERMES ANTIGEN; ISOPROTEIN;

ADULT; AGED; ALTERNATIVE RNA SPLICING; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CELL TYPE; CLEAR CELL CARCINOMA; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; FEMALE; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; CARCINOMA, RENAL CELL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; KIDNEY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROTEIN ISOFORMS; TUMOR CELLS, CULTURED;

EID: 0032839773     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00177-6     Document Type: Article

References (20)

1. Bartolazzi A, Peach R, Aruffo A, et al: Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med 180: 53-66, 1994.
2. Tanabe KK, Nishi T, and Saya H: Novel variants of CD44 arising from alternative splicing: changes in the CD44 alternative splicing pattern of MCF-7 breast carcinoma cells treated with hyaluronidase. Mol Carcinog 7: 212-220, 1993.
3. Miyake H, Kara I, Okamoto I, et al: Interaction between CD44 and hyaluronic acid regulates human prostate cancer development. J Urol 160: 1562-1566, 1998.
4. Tolg C, Hofmann M, Herrlich P, et al: Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res 21: 1225-1229, 1993.
5. Kaufmann M, Heider KH, Sinn HP, et al: CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 345: 615-619, 1995.
6. Fox SB, Fawcett J, Jackson DG, et al: Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res 54: 4539-4546, 1994.
7. Okamoto I, Morisaki T, Sasaki J, et al: Molecular detection of cancer cells by competitive reverse transcription-polymerase chain reaction analysis of specific CD44 variant RNAs. J Natl Cancer Inst 90: 307-315, 1998.
8. Miyake H, Okamoto I, Hara I, et al: Highly specific and sensitive detection of malignancy in urine samples from patients with urothelial cancer by CD44v8-10/CD44v10 competitive RT-PCR. Int J Cancer 79: 560-564, 1998.
9. Miyake H, Hara I, Gohji K, et al: Urinary cytology and competitive reverse transcriptase-polymerase chain reaction analysis of a specific CD44 variant to detect and monitor bladder cancer. J Urol 160: 2004-2008, 1998.
10. Miyake H, Hara I, Yamanaka K, et al: Expression patterns of CD44 adhesion molecule in testicular germ cell tumors and normal testes. Am J Pathol 152: 1157-1160, 1998.
11. Tanabe KK, Ellis LM, and Saya H: Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet 341: 725-726, 1992.
12. Rodriguez C, Monges G, Rouanet P, et al: CD44 expression patterns in breast and colon tumors: a PCR-based study of splice variants. Int J Cancer 64: 347-354, 1995.
13. Miwa T, Watanabe A, Yamada Y, et al: Progression in gastric carcinoma relative to the ratio of CD44 epithelial variant transcript to CD44 hematopoietic variant transcript. Cancer 77: 25-29, 1996.
14. Takano T, Sumizaki H, Nakano K, et al: Increased expression of CD44 variants in differentiated thyroid cancers. Jpn J Cancer Res 87: 1245-1250, 1996.
15. Terpe HJ, Storkel S, Zimmer U, et al: Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation. Am J Pathol 148: 453-463, 1996.
16. Heider KH, Ratschek M, Zatloukal K, et al: Expression of CD44 isoforms in human renal cell carcinoma. Virchows Arch 428: 267-273, 1996.
17. Kan M, Aki M, Akiyama K, et al: High-level expression of the CD44 variant sharing exon v10 in renal cancer. Jpn J Cancer Res 86: 847-853, 1995.
18. de Albe E, Panizo A, Sola I, et al: CD44v6 expression is related to progression in renal epithelial tumors. Histopathology 33: 39-45, 1998.
19. Yoshimura K, Eto H, Miyake H, et al: Messenger ribonucleic acids for fibroblast growth factors and their receptor in human bladder and renal cell carcinoma cell lines. Cancer Lett 103: 91-97, 1996.
20. Takahashi K, Stamenkovic I, Culter M, et al: Keratan sulfate modification of CD44 modulates adhesion to hyaluronate. J Biol Chem 271: 9490-9496, 1996.